Popular on Amzeal
- Michelle Kerr Joins Summit Advisory Board - 255
- Sarah Novotny Joins Kosai as a Board Advisor: A New Chapter for Open Source Leadership - 122
- Summit Technologies Welcomes Angelo Mazzocco to Advisory Board - 117
- Morningscore Secures $700k in Funding to Build the Next Generation of AI SEO and Expand Globally
- OmegaBrand Introduces New Thermal Transfer Ribbons for Honeywell PC45t Printers
- Streetwise Artificial Intelligence Technology
- Stan Fitzgerald: A Profile in Resilience and Leadership with VFAF Veterans for America First Organizational Support for a Presidential Pardon
- Nola Blue Records signs legendary Maria Muldaur and estimable Candice Ivory
- IEEE Milwaukee 2024 Science Kits for Public Library Grant
- National GEM Consortium Celebrates Dr. Johney Green Jr's Selection as Director of Savannah River
Similar on Amzeal
- Dr. Lauren Anderson Led a Successful CE Event: Digital Planning and Execution
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- The Dental Specialists in Newton, MA, Introduces Cutting-Edge 3Shape TRIOS 5 Intraoral Scanner
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
- Acmeware and Interlace Health Join Forces to Revolutionize Downtime Solutions
- Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
- New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
Sempulse announces U.S. FDA 510(k) Clearance and the Commercial Launch of the Halo Vital Signs Moni
Amzeal News/10564519
SAN MARCOS, Texas - Amzeal -- Sempulse today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sempulse Halo Vital Signs Monitoring System. The miniature wearable device is a durable, non-invasive, remote vital signs monitoring system that captures 5 major vital signs (SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature) for general monitoring, Remote Patient Monitoring (RPM), telemedicine, and chronic disease monitoring while at rest or in motion. It is the first FDA clearance the company has received.
The Halo monitor may be used in clinics, hospitals, emergency rooms, medical transports, the home, and the workplace, including military medicine settings in the field. The Halo monitor is capable of being used during triage and trauma scenarios and is reusable, transportable, and for use in all types of ambulances.
More on Amzeal News
Also included in the Halo Platform are LiveCharts and Command Cloud. LiveCharts is an app that enables the Halo monitor. It displays vital signs and prioritizes dozens of patients. Command Cloud is cloud-based software that centralizes vital signs management and allows remote medical resources to view and prioritize patients around the globe.
Kurt Stump, CEO of Sempulse, remarked that "achieving FDA clearance is the culmination of all of the hard work by the team over the past eight years and an exciting next step as people see and use our platform to save lives. From having our patents issued to the challenges of user testing with the Navy SEALs to monitoring patients during the pandemic, we have come a long way. We officially launch our Halo Platform and the Halo device with great momentum to undertake deployments with the U.S. Military and forward-thinking police and fire departments later this year."
Millions of people use smart watches and other wearables in an attempt to monitor themselves while in motion throughout the day, but those devices do not provide medical-grade data and are not FDA cleared. Millions more attend telemedicine visits every year without accurate vital signs for a clinician to properly diagnose them. Even more are not monitored while they work or recover. The Sempulse Halo can accurately provide vital signs for all of these use cases.
More on Amzeal News
Sempulse is a medical device manufacturer with offices in San Marcos, TX. They have developed and patented a novel, non-invasive vital signs sensor that adheres to the neck and the back of the ear and acquires multiple patients' vital signs, including SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature, plus geolocation and a wealth of environmental information. They are first targeting their technology at the military and first responders, but their sensors are equally capable in the civilian world.
More information can be found at https://sempulse.com/.
The Halo monitor may be used in clinics, hospitals, emergency rooms, medical transports, the home, and the workplace, including military medicine settings in the field. The Halo monitor is capable of being used during triage and trauma scenarios and is reusable, transportable, and for use in all types of ambulances.
More on Amzeal News
- Manchester Insurance Announces Best Rates in Florida for Home Insurance
- New Middle East Partnership for up to $40 Million Supporting Entry Into Emerging Global MOBA Digital Game Arena: NIP Group (Stock Symbol: NIPG)
- Blitsor: The Future of Streaming That YouTube Fears!
- Saelig Introduces Economical Harogic PX Series 40GHz Realtime Spectrum Analyzers
- King Dumpsters Canton Launches Affordable, Reliable Dumpster Rental Services in Canton, Ohio
Also included in the Halo Platform are LiveCharts and Command Cloud. LiveCharts is an app that enables the Halo monitor. It displays vital signs and prioritizes dozens of patients. Command Cloud is cloud-based software that centralizes vital signs management and allows remote medical resources to view and prioritize patients around the globe.
Kurt Stump, CEO of Sempulse, remarked that "achieving FDA clearance is the culmination of all of the hard work by the team over the past eight years and an exciting next step as people see and use our platform to save lives. From having our patents issued to the challenges of user testing with the Navy SEALs to monitoring patients during the pandemic, we have come a long way. We officially launch our Halo Platform and the Halo device with great momentum to undertake deployments with the U.S. Military and forward-thinking police and fire departments later this year."
Millions of people use smart watches and other wearables in an attempt to monitor themselves while in motion throughout the day, but those devices do not provide medical-grade data and are not FDA cleared. Millions more attend telemedicine visits every year without accurate vital signs for a clinician to properly diagnose them. Even more are not monitored while they work or recover. The Sempulse Halo can accurately provide vital signs for all of these use cases.
More on Amzeal News
- Matthew Cossolotto's The Joy of Public Speaking – Helping Readers Move from Stage Fright to Stage Delight – Wins 2024 Maincrest Media Book Award
- Lady Bird Laser Spa: Empowering Beauty with Advanced Skin Treatments and Exceptional Service
- Profitable Exciting New Entry Into Emerging Global MOBA Digital Game Arena, Plus New Strategic Partnership with The9 Limited: NIP Group; Stock: NIPG
- Biden's Farewell Fails Workers: Broken Promises, Billionaires First, and Americans Left Behind
- A Historic Night Awaits: RNHA Celebrating the Power of the Latino Vote at Inauguration 2025
Sempulse is a medical device manufacturer with offices in San Marcos, TX. They have developed and patented a novel, non-invasive vital signs sensor that adheres to the neck and the back of the ear and acquires multiple patients' vital signs, including SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature, plus geolocation and a wealth of environmental information. They are first targeting their technology at the military and first responders, but their sensors are equally capable in the civilian world.
More information can be found at https://sempulse.com/.
Source: Sempulse
Filed Under: Medical
0 Comments
Latest on Amzeal News
- Anti-Racism Song from Neal Fox Drops in Time for Martin Luther King Day
- SGS Partners with FPD to Launch Innovative Simulation-driven Training Solution for Clinicians
- Genpak Expands Foodservice Packaging to Include Durable, Polypropylene Bowls
- DayPass Expands to 50 New Destinations in 2024, Bringing Luxury Day Experiences to Travelers and Locals
- Game-Changing Sponsorship Platform Launches Ahead of the Super Bowl
- Dr. Lauren Anderson Led a Successful CE Event: Digital Planning and Execution
- "One World in a New World" Amplifies Voices of Transformation, Resilience, and Global Connection
- WalkerHughes Insurance Expands Footprint With Acquisition of Independent Brokers Agency LLC
- Hawk Tuah VIP Shop launches Exclusive Merchandise line for Viral Meme Fans
- Perfumeo x Google: Perfumeo Supported by Google to Revolutionize Smart Homes, Joins 'Google for Startups' Accelerator
- Orcas Island Property Owner Returns Two Prime Waterfront Properties to the Market
- Muench Workshops Welcomes New Partners Luke Dray and Sara Linssen, Announces Retirement of Andy Williams
- Qualis LLC welcomes Darren Gero as VP of Business Development
- Blood Moons 2025 and Darkened Sun: Four Prophetic Signs We Can't Ignore
- NuNorm Announces Stop Soldier Suicide as This Year's EQUAL Grant Recipient
- BKM Capital Partners Releases White Paper Examining E-Commerce's Profound Impact on Industrial Real Estate
- Darrin Jones: The Creative Force Behind the Trends—Raising Questions About Influence in The Weeknd's Music
- Bloomster Revolutionizes Holistic Learning with Free eBook Library for Parents & Adolescents (Ages 10-15)
- Foresight Practitioner Conference 2025 – Dates, Venue, Speakers, And Competition Finalists Announced
- ThoroughCare Partners with CareCo AI to Enhance Efficiency and Patient Care